In 2023, the import of antisera and other blood fractions to the US stood at approximately 8.5 million kilograms. The forecasted data from 2024 to 2028 shows a steady growth in imports, rising from 8.69 million kilograms in 2024 to 9.51 million kilograms by 2028. This consistent year-on-year increase reflects a growing demand for these products in the US market.

Year-on-year growth rates in import volumes are anticipated to range around 2.4% for each consecutive year. This upward trend indicates robust demand possibly fueled by expanding healthcare needs and technological advancements in medical treatments.

Future trends to watch:

Potential impacts of technological innovation in synthetic or alternative biological products.
Regulatory changes that may affect import processes or product demand.
Global health trends that could further boost demand for antisera and blood fractions.